ZA201401840B - Endoglycosidase from streptococcus pyogenes and methods using it - Google Patents

Endoglycosidase from streptococcus pyogenes and methods using it

Info

Publication number
ZA201401840B
ZA201401840B ZA2014/01840A ZA201401840A ZA201401840B ZA 201401840 B ZA201401840 B ZA 201401840B ZA 2014/01840 A ZA2014/01840 A ZA 2014/01840A ZA 201401840 A ZA201401840 A ZA 201401840A ZA 201401840 B ZA201401840 B ZA 201401840B
Authority
ZA
South Africa
Prior art keywords
endoglycosidase
methods
streptococcus pyogenes
pyogenes
streptococcus
Prior art date
Application number
ZA2014/01840A
Other languages
English (en)
Inventor
Jonathan Sjogren
Maria Allhorn
Mattias Collin
Original Assignee
Genovis Ab
Priority date (The priority date is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the date listed.)
Filing date
Publication date
Application filed by Genovis Ab filed Critical Genovis Ab
Publication of ZA201401840B publication Critical patent/ZA201401840B/en

Links

Classifications

    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • C12N9/2405Glucanases
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12NMICROORGANISMS OR ENZYMES; COMPOSITIONS THEREOF; PROPAGATING, PRESERVING, OR MAINTAINING MICROORGANISMS; MUTATION OR GENETIC ENGINEERING; CULTURE MEDIA
    • C12N9/00Enzymes; Proenzymes; Compositions thereof; Processes for preparing, activating, inhibiting, separating or purifying enzymes
    • C12N9/14Hydrolases (3)
    • C12N9/24Hydrolases (3) acting on glycosyl compounds (3.2)
    • C12N9/2402Hydrolases (3) acting on glycosyl compounds (3.2) hydrolysing O- and S- glycosyl compounds (3.2.1)
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12PFERMENTATION OR ENZYME-USING PROCESSES TO SYNTHESISE A DESIRED CHEMICAL COMPOUND OR COMPOSITION OR TO SEPARATE OPTICAL ISOMERS FROM A RACEMIC MIXTURE
    • C12P21/00Preparation of peptides or proteins
    • C12P21/005Glycopeptides, glycoproteins
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12QMEASURING OR TESTING PROCESSES INVOLVING ENZYMES, NUCLEIC ACIDS OR MICROORGANISMS; COMPOSITIONS OR TEST PAPERS THEREFOR; PROCESSES OF PREPARING SUCH COMPOSITIONS; CONDITION-RESPONSIVE CONTROL IN MICROBIOLOGICAL OR ENZYMOLOGICAL PROCESSES
    • C12Q1/00Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions
    • C12Q1/34Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase
    • C12Q1/37Measuring or testing processes involving enzymes, nucleic acids or microorganisms; Compositions therefor; Processes of preparing such compositions involving hydrolase involving peptidase or proteinase
    • CCHEMISTRY; METALLURGY
    • C12BIOCHEMISTRY; BEER; SPIRITS; WINE; VINEGAR; MICROBIOLOGY; ENZYMOLOGY; MUTATION OR GENETIC ENGINEERING
    • C12YENZYMES
    • C12Y302/00Hydrolases acting on glycosyl compounds, i.e. glycosylases (3.2)
    • C12Y302/01Glycosidases, i.e. enzymes hydrolysing O- and S-glycosyl compounds (3.2.1)
    • C12Y302/01096Mannosyl-glycoprotein endo-beta-N-acetylglucosaminidase (3.2.1.96)
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/53Immunoassay; Biospecific binding assay; Materials therefor
    • G01N33/569Immunoassay; Biospecific binding assay; Materials therefor for microorganisms, e.g. protozoa, bacteria, viruses
    • G01N33/56911Bacteria
    • G01N33/56944Streptococcus
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N33/00Investigating or analysing materials by specific methods not covered by groups G01N1/00 - G01N31/00
    • G01N33/48Biological material, e.g. blood, urine; Haemocytometers
    • G01N33/50Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing
    • G01N33/68Chemical analysis of biological material, e.g. blood, urine; Testing involving biospecific ligand binding methods; Immunological testing involving proteins, peptides or amino acids
    • G01N33/6854Immunoglobulins
    • CCHEMISTRY; METALLURGY
    • C07ORGANIC CHEMISTRY
    • C07KPEPTIDES
    • C07K2317/00Immunoglobulins specific features
    • C07K2317/40Immunoglobulins specific features characterized by post-translational modification
    • C07K2317/41Glycosylation, sialylation, or fucosylation
    • GPHYSICS
    • G01MEASURING; TESTING
    • G01NINVESTIGATING OR ANALYSING MATERIALS BY DETERMINING THEIR CHEMICAL OR PHYSICAL PROPERTIES
    • G01N2469/00Immunoassays for the detection of microorganisms
    • G01N2469/20Detection of antibodies in sample from host which are directed against antigens from microorganisms

Landscapes

  • Health & Medical Sciences (AREA)
  • Life Sciences & Earth Sciences (AREA)
  • Chemical & Material Sciences (AREA)
  • Engineering & Computer Science (AREA)
  • Organic Chemistry (AREA)
  • Zoology (AREA)
  • Wood Science & Technology (AREA)
  • Molecular Biology (AREA)
  • Bioinformatics & Cheminformatics (AREA)
  • Genetics & Genomics (AREA)
  • General Health & Medical Sciences (AREA)
  • Biochemistry (AREA)
  • Immunology (AREA)
  • Biomedical Technology (AREA)
  • Biotechnology (AREA)
  • Microbiology (AREA)
  • General Engineering & Computer Science (AREA)
  • Medicinal Chemistry (AREA)
  • Hematology (AREA)
  • Urology & Nephrology (AREA)
  • Physics & Mathematics (AREA)
  • Analytical Chemistry (AREA)
  • Proteomics, Peptides & Aminoacids (AREA)
  • Pathology (AREA)
  • Food Science & Technology (AREA)
  • Cell Biology (AREA)
  • General Physics & Mathematics (AREA)
  • Virology (AREA)
  • Tropical Medicine & Parasitology (AREA)
  • Biophysics (AREA)
  • General Chemical & Material Sciences (AREA)
  • Chemical Kinetics & Catalysis (AREA)
  • Enzymes And Modification Thereof (AREA)
  • Peptides Or Proteins (AREA)
  • Measuring Or Testing Involving Enzymes Or Micro-Organisms (AREA)
  • Micro-Organisms Or Cultivation Processes Thereof (AREA)
  • Preparation Of Compounds By Using Micro-Organisms (AREA)
ZA2014/01840A 2011-09-13 2014-03-12 Endoglycosidase from streptococcus pyogenes and methods using it ZA201401840B (en)

Applications Claiming Priority (2)

Application Number Priority Date Filing Date Title
GB201115841A GB201115841D0 (en) 2011-09-13 2011-09-13 Protein and method
PCT/EP2012/067841 WO2013037824A1 (en) 2011-09-13 2012-09-12 Endoglycosidase from streptococcus pyogenes and methods using it

Publications (1)

Publication Number Publication Date
ZA201401840B true ZA201401840B (en) 2018-05-30

Family

ID=44908522

Family Applications (1)

Application Number Title Priority Date Filing Date
ZA2014/01840A ZA201401840B (en) 2011-09-13 2014-03-12 Endoglycosidase from streptococcus pyogenes and methods using it

Country Status (20)

Country Link
US (1) US9493752B2 (cg-RX-API-DMAC7.html)
EP (1) EP2756077B1 (cg-RX-API-DMAC7.html)
JP (1) JP6076349B2 (cg-RX-API-DMAC7.html)
KR (1) KR102001427B1 (cg-RX-API-DMAC7.html)
CN (1) CN103946377B (cg-RX-API-DMAC7.html)
AU (1) AU2012307461B2 (cg-RX-API-DMAC7.html)
BR (1) BR112014005816A2 (cg-RX-API-DMAC7.html)
CA (1) CA2848230C (cg-RX-API-DMAC7.html)
DK (1) DK2756077T3 (cg-RX-API-DMAC7.html)
EA (1) EA028490B8 (cg-RX-API-DMAC7.html)
ES (1) ES2627334T3 (cg-RX-API-DMAC7.html)
GB (2) GB201115841D0 (cg-RX-API-DMAC7.html)
IL (1) IL231410A0 (cg-RX-API-DMAC7.html)
IN (1) IN2014CN02163A (cg-RX-API-DMAC7.html)
MX (1) MX347727B (cg-RX-API-DMAC7.html)
PL (1) PL2756077T3 (cg-RX-API-DMAC7.html)
PT (1) PT2756077T (cg-RX-API-DMAC7.html)
SG (1) SG11201400505YA (cg-RX-API-DMAC7.html)
WO (1) WO2013037824A1 (cg-RX-API-DMAC7.html)
ZA (1) ZA201401840B (cg-RX-API-DMAC7.html)

Families Citing this family (34)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
AU2002216863B8 (en) * 2000-12-21 2008-03-20 Id Biomedical Corporation Streptococcus pyogenes antigens and corresponding DNA fragments
RS64329B1 (sr) 2012-10-23 2023-08-31 Synaffix Bv Modifikovano antitelo, konjugat antitela i postupak za njihovo pripremanje
WO2014177771A1 (en) 2013-05-02 2014-11-06 Glykos Finland Oy Conjugates of a glycoprotein or a glycan with a toxic payload
EP2935608A1 (en) 2013-10-14 2015-10-28 SynAffix B.V. Modified glycoprotein, protein-conjugate and process for the preparation thereof
EP3929301A1 (en) 2013-10-14 2021-12-29 SynAffix B.V. Glycoengineered antibody, antibody-conjugate and methods for their preparation
WO2015057064A1 (en) 2013-10-14 2015-04-23 Synaffix B.V. Modified glycoprotein, protein-conjugate and process for the preparation thereof
WO2015057065A1 (en) 2013-10-14 2015-04-23 Synaffix B.V. Glycoengineered antibody, antibody-conjugate and methods for their preparation
GB201318490D0 (en) * 2013-10-18 2013-12-04 Genovis Ab Method
EP3097079B1 (en) 2014-01-24 2021-05-12 SynAffix B.V. Process for the cycloaddition of a hetero(aryl) 1,3-dipole compound with a (hetero)cycloalkyne
CA2954934C (en) 2014-06-30 2023-09-26 Glykos Finland Oy Drug derivative and conjugates
GB201413240D0 (en) 2014-07-25 2014-09-10 Hansa Medical Ab Method
EP3177633B1 (en) 2014-08-04 2022-07-20 SynAffix B.V. Process for the modification of a glycoprotein using a beta-(1,4)-n-acetylgalactosaminyltransferase or a mutant thereof
GB201502306D0 (en) * 2015-02-12 2015-04-01 Hansa Medical Ab Protein
GB201502305D0 (en) * 2015-02-12 2015-04-01 Hansa Medical Ab Protein
JP6966162B2 (ja) 2015-04-23 2021-11-10 シンアフィックス ビー.ブイ. β(1,4)−N−アセチルガラクトサミニルトランスフェラーゼであるか又はそれに由来するグリコシルトランスフェラーゼを用いる糖タンパク質の改変方法
US11008601B2 (en) 2016-01-15 2021-05-18 University Of Maryland Endo-S2 mutants as glycosynthases, method of making and use for glycoengineering of glycoproteins
SG11201806639VA (en) * 2016-02-04 2018-09-27 Genovis Ab New streptococcal proteases
TWI727883B (zh) * 2016-08-24 2021-05-11 醣基生醫股份有限公司 利用醣苷內切酶突變體重塑醣蛋白及其使用方法
FI3630968T3 (fi) 2017-05-26 2024-07-24 Genovis Ab Entsyymejä glykaanien analysointiin
US20210228738A1 (en) 2017-07-17 2021-07-29 INSERM (Institut National de la Santé et de la Recherche Médicale) Compositions and methods for increasing or enhancing transduction of gene therapy vectors and for removing or reducing immunoglobulins
CN112672764A (zh) 2018-06-19 2021-04-16 格莱科斯生物医药公司 结合物
CN112672765A (zh) 2018-06-29 2021-04-16 格莱科斯生物医药公司 结合物
US20230038373A1 (en) 2019-12-18 2023-02-09 Glykos Biomedical Oy Stabile conjugate
CN111044731B (zh) * 2019-12-19 2021-05-07 北京科技大学 脉冲温育免疫反应分离富集多肽药物中肽类杂质的方法
WO2021142199A1 (en) 2020-01-09 2021-07-15 Mersana Therapeutics, Inc. Site specific antibody-drug conjugates with peptide-containing linkers
GB202002072D0 (en) * 2020-02-14 2020-04-01 Hansa Biopharma AB immunoglobulin detection and associated therapies
JP2023541698A (ja) * 2020-09-21 2023-10-03 上海宝済薬業有限公司 組合せ医薬及びその使用
TW202241954A (zh) 2021-01-04 2022-11-01 美商梅爾莎納醫療公司 靶向b7-h4之抗體-藥物共軛體和使用彼之方法
EP4079848A1 (en) 2021-04-22 2022-10-26 Genovis Ab Immunoglobulin cleaving enzyme
CN115873833B (zh) * 2022-11-08 2024-08-16 上海泰昶生物技术有限公司 生产免疫球蛋白g降解酶的工程菌株和工艺
CN117165643B (zh) * 2023-08-17 2025-10-28 山东大学 一种糖苷内切酶在水解高甘露糖型n-糖蛋白中的应用
WO2025098484A1 (zh) * 2023-11-10 2025-05-15 上海齐鲁制药研究中心有限公司 新型Endo S2突变体酶
WO2025180451A1 (zh) * 2024-03-01 2025-09-04 上海齐鲁制药研究中心有限公司 新型Endo S2突变体酶
WO2025248500A1 (en) 2024-05-31 2025-12-04 Janssen Biotech, Inc. Antibody drug conjugates that target enpp3

Family Cites Families (5)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
GB0130228D0 (en) 2001-12-18 2002-02-06 Hansa Medica Ab Protein
GB0624874D0 (en) * 2006-12-13 2007-01-24 Hansa Medical Ab Treatment
CN101889082A (zh) * 2007-09-14 2010-11-17 季诺维斯公司 用于解离Fcgamma-受体-IgG复合物以及纯化与检测IgG的方法和试剂盒
GB0821100D0 (en) 2008-11-18 2008-12-24 Hansa Medical Ab Antibodies
ES2528321T3 (es) * 2009-10-02 2015-02-06 Roche Glycart Ag Detección de a-fucosilación en anticuerpos

Also Published As

Publication number Publication date
MX2014002906A (es) 2014-10-17
IN2014CN02163A (cg-RX-API-DMAC7.html) 2015-05-29
EP2756077A1 (en) 2014-07-23
CN103946377A (zh) 2014-07-23
IL231410A0 (en) 2014-04-30
JP6076349B2 (ja) 2017-02-08
EA028490B1 (ru) 2017-11-30
CA2848230C (en) 2020-03-24
PT2756077T (pt) 2017-06-21
US9493752B2 (en) 2016-11-15
SG11201400505YA (en) 2014-04-28
GB201115841D0 (en) 2011-10-26
DK2756077T3 (en) 2017-07-03
JP2014531205A (ja) 2014-11-27
PL2756077T3 (pl) 2017-09-29
CN103946377B (zh) 2016-10-05
KR20140081813A (ko) 2014-07-01
AU2012307461B2 (en) 2016-08-18
MX347727B (es) 2017-05-10
WO2013037824A1 (en) 2013-03-21
AU2012307461A1 (en) 2014-03-27
GB201406321D0 (en) 2014-05-21
CA2848230A1 (en) 2013-03-21
EP2756077B1 (en) 2017-03-29
EA201490447A1 (ru) 2014-09-30
GB2509284A (en) 2014-06-25
BR112014005816A2 (pt) 2020-12-29
KR102001427B1 (ko) 2019-07-18
NZ622172A (en) 2016-04-29
EA028490B8 (ru) 2018-01-31
US20140302519A1 (en) 2014-10-09
ES2627334T3 (es) 2017-07-27

Similar Documents

Publication Publication Date Title
ZA201401840B (en) Endoglycosidase from streptococcus pyogenes and methods using it
GB201107863D0 (en) Method and product
ZA201309700B (en) Electrodesalination system and method
GB201117278D0 (en) Method and system
GB201101966D0 (en) Infrastructure equipmnet and method
IL230511A0 (en) 4-Imidazopyridazine-1-yl-benzamides and 4-imidazotriazine-1-yl-benzamides as btk inhibitors
GB201011971D0 (en) Methods and product
GB2505169B (en) decoder and method
GB201110783D0 (en) Methods and uses
GB201104983D0 (en) Receiver and method
GB201118985D0 (en) Product and method
GB201122089D0 (en) Telecomunication apparatus and methods
GB201113610D0 (en) Product and method
EP2727068A4 (en) DYNAMIC UPDATE SYSTEM AND METHOD
GB201121406D0 (en) Systems and methods
EP2729906A4 (en) SYSTEMS AND METHOD FOR PRODUCT CONFIGURATION
GB201112981D0 (en) An arrangement and method
GB201116774D0 (en) Uses and methods
ZA201400067B (en) Chainage calculation methodology and system
GB201401983D0 (en) Loyalty systems and methods
GB201105569D0 (en) Apparatus and methods
GB201112970D0 (en) An arrangement and method
GB2502227B (en) Audio association systems and methods
GB201108490D0 (en) Methods and uses
GB201104534D0 (en) Receiver and methods